Solid Biosciences (SLDB) Other Non-Current Assets (2017 - 2026)

Solid Biosciences (SLDB) has 10 years of Other Non-Current Assets data on file, last reported at $708000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 64.12% year-over-year to $708000.0; the trailing twelve-month figure through Mar 2026 stood at $708000.0 (down 64.12% YoY), and the FY2025 full-year result was $768000.0, down 60.66% from the prior year.
• Other Non-Current Assets retreated to $708000.0 in Q1 2026, from $768000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $2.1 million in Q1 2022 to a low of $175000.0 in Q4 2022.
• A 5-year average of $1.6 million and a median of $1.8 million in 2022 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets sank 91.55% in 2022 and soared 947.43% in 2023, its largest moves.
• Tracing SLDB's Other Non-Current Assets over 5 years: stood at $175000.0 in 2022, then soared by 947.43% to $1.8 million in 2023, then advanced by 6.49% to $2.0 million in 2024, then tumbled by 60.66% to $768000.0 in 2025, then fell by 7.81% to $708000.0 in 2026.
• Business Quant data shows SLDB's Other Non-Current Assets at $708000.0 in Q1 2026, $768000.0 in Q4 2025, and $247000.0 in Q3 2025.